Begin main content

Reports

We found 4642 result(s)

Drug treatments for Alzheimer’s disease. I. A comparative analysis of clinical trials

Published on: January 1, 2000
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Wolfson C, Moride Y, Perrault A, Momoli F, Demers L, Oremus M. Drug treatments for Alzheimer's disease. I. A comparative analysis of clinical trials. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2000. Alzheimer's disease is a devastating disorder of the elderly, which is expected to become a major publ...

Tags

Metrifonate, Alzheimer Disease, Cholinesterase Inhibitors, Alzheimer, Alzheimers, Alzheimer’s, Donepezil, Rivastigmine, Maladie, Anticholinesterasiques, MA, Arbre aux quarante écus, Donépézil

Surveillance mammography after treatment for primary breast cancer

Published on: January 1, 2000
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: McGahan L, Noorani HZ. Surveillance mammography after treatment for primary breast cancer. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2000. Considerable controversy exists regarding the frequency and intensity of surveillance following treatment for breast cancer. This paper is a systematic, structur...

Tags

Mammography, Breast Cancer, Lymphoma, Breast cancer, cancer du sein, Lymphoma, Surveillance, Tumeur sein, Mammographie, Dépistage systématique, Cliché mammaire, Dépistage du cancer du sein

Drug treatments for Alzheimer’s disease. II. A review of outcome measures in clinical trials

Published on: January 1, 2000
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Wolfson C, Moride Y, Perrault A, Momoli F, Demers L, Oremus M. Drug Treatments for Alzheimer’s Disease. Part 2: A Review of Outcome Measures in Clinical Trials. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2000. Alzheimer’s disease is a devastating disorder of the elderly, which is expected to become a...

Tags

Alzheimer Disease, Trichlorfon, Ginkgo biloba, Cholinesterase Inhibitors, Maidenhair Tree, Metrifonate, Alzheimer, Alzheimers, Alzheimer’s, Donepezil, Rivastigmine, Maladie, Anticholinesterasiques, MA, Arbre aux quarante écus, Donépézil

Use of Cisapride in patients with non-ulcer dyspepsia: a meta-analysis of randomized trials

Published on: January 1, 2000
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Shukla VK, Otten N, Dubé C, Moher D. Use of cisapride in patients with non-ulcer dyspepsia: a meta-analysis of randomized trials. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2000. Objectives To determine the relative effectiveness of cisapride in the treatment of non-ulcer dyspepsia in comparison to p...

Tags

Cisapride, Gastrointestinal Agents, Histamine H2 Antagonists, Dyspepsia, Treatment Outcome, Meta-Analysis, Indigestion, Aminopyridines, Gastrointestinal Tract, Gastrointestinal tract, Agents gastrointestinaux, Antihistaminiques H2, Dyspepsie, Méta-analyse, Antagonistes H2, Stomatite aphteuse, Chimiothérapie, Voie externe, Amlexanox, Apthera, Aphte, Anti-inflammatoires

Criteria for selection of adult recipients for heart, cadaveric kidney, and liver transplantation

Published on: July 1, 1999
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Noorani H, McGahan L. Criteria for selection of adult recipients for heart, cadaveric kidney, and liver transplantation. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1999. The demand for solid organs for transplantation continues to exceed, by far, the supply available in Canada. As a result of the sev...

Tags

Organ Transplantation, Patient Selection, Heart Diseases, Kidney, Liver, Transplant Recipients, Liver, Surgery, Heart transplants, Transplant recipientsHeart transplants

Economic analysis of Erythropoietin Use in Surgery

Published on: March 9, 1999
Result type: Reports

Cite as: Otten N. Economic evaluation of erythropoietin use in surgery. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1998. The Issue The use of allogeneic (donor) blood transfusion is associated with risks such as the transmission of infectious diseases including HIV and Hepatitis B and C. The perioperative use...

Tags

Erythropoietin, Arthroplasty, Hip, Cardiac Surgical Procedures, Blood Transfusion, Autotransfusion, Blood Transfusion, Autologous, Economics, Arthroplasty, Replacement, Hip, Blood, Surgery, Replacement, Autologous, EPO, Hip replacement, Open heart surgery, Blood banking, Érythropoïétine, Arthroplastie hanche, Interventions chirurgie cardiaque, Transfusion sanguine autologue, Prothèse totale hanche, Chirurgie cardiaque, Évaluation économique, Réserves de sang, ***, EPO, ***

Cilostazol: a replacement for pentoxifylline?

Published on: January 1, 1999
Result type: Reports

Tags

Intermittent Claudication, Pentoxifylline, Phosphodiesterase Inhibitors, Cost-Benefit Analysis, Comparative Study, Peripheral vascular disease, IC, Cilostazol, Comparison, Economic, Claudication intermittente, Inhibiteurs phosphodiestérase, Analyse coût bénéfice, Étude comparative, CI, Coût potentiel, Comparaison

Cox-2 Inhibitors: A Role in Alzheimer’s Disease?

Published on: January 1, 1999
Result type: Reports

Tags

Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Alzheimer Disease, Drug Therapy, COX-2 Inhibitors, Anti-Inflammatories, NSAIDs, Anti-Inflammatory Agents, Non-Steroidal, Alzheimer, Non-Steroidal, Alzheimer’s, Alzheimers, Inhibiteur cyclooxygénase, Antiinflammatoires nonstéroïdiens, maladie, Chimiothérapie, Inhibiteurs de la COX-2, Anti-inflammatoires, AINS

Insulin Lispro: a critical evaluation

Published on: January 1, 1999
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Tags

Hypoglycemic Agents, Lispro, Diabetes Mellitus, Insulin Lispro, Diabetes, Mellitus, Non-Insulin-Dependent, Insulin-Dependent, Type 2 Diabetes, Type 1 Diabetes, Diabète non insulinodépendant, Diabète insulinodépendant, Hypoglycémiants, Chimiothérapie, Diabète de type II, Diabète de type I

Etanercept: Anti-Tumor Necrosis Factor Therapy for Rheumatoid Arthritis

Published on: January 1, 1999
Result type: Reports

Tags

Anti-Inflammatory Agents, Arthritis, Antirheumatic Agents, Tumor Necrosis Factor, Anti-Inflammatories, NSAIDs, Rheumatoid Arthritis, TNF Receptors, DMARD, Anti-Inflammatory Agents, Non-Steroidal, Arthritis, Juvenile Rheumatoid, Arthritis, Rheumatoid, Receptors, Tumor Necrosis Factor, Arthritis, Musculoskeletal, Non-Steroidal, enbrel, Rheumatoid, Juvenile Rheumatoid, Etanercept, Receptors, DMARDs, Antiinflammatoires nonstéroïdiens, Polyarthrite rhumatoïde, Polyarthrite chronique juvénile, Agents antirhumatismaux, Récepteur facteur nécrose tumorale, Anti-inflammatoires, Polyarthrite chronique évolutive, Récepteur TNF